Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erming Tian

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Leukemia Research|April 28, 2009
OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locusThea Kristin Våtsveen, Erming Tian, Stine H Kresse, et al.
American Journal of Hematology|May 29, 2021
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myelomaMeera Mohan, Aniko Szabo, Naveen Yarlagadda, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Blood|April 13, 2012
Prediction of cytogenetic abnormalities with gene expression profilesYiming Zhou, Qing Zhang, Owen Stephens, et al.
Genes, Chromosomes & Cancer|June 17, 2016
VOLIN and KJON-Two novel hyperdiploid myeloma cell linesThea Kristin Våtsveen, Magne Børset, Aida Dikic, et al.
Bone|February 8, 2021
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experienceMeera Mohan, Manoj Kumar, Rohan Samant, et al.
Cancer|June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myelomaMeera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Blood Advances|November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaMeera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Leukemia Research|April 28, 2009
OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locusThea Kristin Våtsveen, Erming Tian, Stine H Kresse, et al.
American Journal of Hematology|May 29, 2021
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myelomaMeera Mohan, Aniko Szabo, Naveen Yarlagadda, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Blood|April 13, 2012
Prediction of cytogenetic abnormalities with gene expression profilesYiming Zhou, Qing Zhang, Owen Stephens, et al.
Genes, Chromosomes & Cancer|June 17, 2016
VOLIN and KJON-Two novel hyperdiploid myeloma cell linesThea Kristin Våtsveen, Magne Børset, Aida Dikic, et al.
Bone|February 8, 2021
Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experienceMeera Mohan, Manoj Kumar, Rohan Samant, et al.
Cancer|June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myelomaMeera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Blood Advances|November 22, 2021
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myelomaMeera Mohan, Samantha Kendrick, Aniko Szabo, et al.
Pageof 5